Stimatix GI

Stomal Management Solutions

Health Tech & Life Sciences
Acquired (Inactive) by B. Braun Medical SAS on Apr 2018 - closed due to acquisition

Company Overview

Snapshot

Founded in June 2009 by Yaron Daniel Raiter, Stimatix GI operates with 1–10 employees. The company secured funding across two rounds from two investors. In April 2018, Stimatix GI was acquired by B. Braun Medical SAS.

Business overview

Stimatix GI develops medical devices for stomal management, focusing on improving the quality of life for individuals with stomas. Its core product, the artificial ostomy sphincter (AOS) series, including the AOS-C2000, aims to restore continence and manage bowel content for people with colostomies. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Medical Treatment & Therapeutics markets, serving both healthcare providers and patients globally.

Company Intelligence Q&A

When was Stimatix GI founded?
Stimatix GI was founded in June 2009.
Who founded Stimatix GI?
Stimatix GI was co-founded by Yaron Daniel Raiter.
What is Stimatix GI's primary product?
Stimatix GI's primary product is the artificial ostomy sphincter (AOS) series, designed to improve bowel content control and management for people with stomas.
When was Stimatix GI acquired and by whom?
Stimatix GI was acquired by B. Braun Medical SAS in April 2018.

External links